What are the trends and variations in oral anticoagulant choice among incident OAC users with nonvalvular AF between 2010 and 2017?
Between 2010 and 2017, NOAC prescriptions increased substantially for nonvalvular AF, with apixaban driving the increase, though warfarin and apixaban remained preferred for elderly and higher-risk patients.
NOAC prescriptions have increased substantially among incident OAC users with nonvalvular AF, predominantly driven by increased prescription of apixaban. Warfarin and apixaban were generally preferred for elderly patients, patients with higher stroke or bleeding risk, and patients with more comorbidities.
Zhu et al. (Tue,) studied this question.